NCT05684640View on ClinicalTrials.gov

A Single and Multiple Dose of Rodatristat Ethyl in Healthy Adult Subjects to Evaluate the Effect of Food and Safety

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 29, 2022

Primary Completion Date

January 17, 2023

Study Completion Date

January 17, 2023

Conditions
Healthy
Interventions
DRUG

Rodatristat Ethyl

Tablets, Oral, 600mg, QD

DRUG

Placebo

Tablets, Oral, 0mg, BID

Trial Locations (1)

78744

PPD Development, Austin

Sponsors

Collaborators (1)

PPD Development, LP
All Listed Sponsors
collaborator

PPD Development, LP

INDUSTRY

lead

Altavant Sciences GmbH

INDUSTRY